These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25785392)

  • 1. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology.
    Shete G; Pawar YB; Thanki K; Jain S; Bansal AK
    Mol Pharm; 2015 Apr; 12(4):1158-70. PubMed ID: 25785392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocrystalline solid dispersions (NSD) of hesperetin (HRN) for prevention of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in Sprague-Dawley (SD) rats.
    Sheokand S; Navik U; Bansal AK
    Eur J Pharm Sci; 2019 Feb; 128():240-249. PubMed ID: 30553062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Mannitol on Nucleation and Crystal Growth of Amorphous Flavonoids: Implications on the Formation of Nanocrystalline Solid Dispersion.
    Shete G; Modi SR; Bansal AK
    J Pharm Sci; 2015 Nov; 104(11):3789-3797. PubMed ID: 26183113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of generation of drug nanocrystals in celecoxib: mannitol nanocrystalline solid dispersion.
    Bhatt V; Shete G; Bansal AK
    Int J Pharm; 2015 Nov; 495(1):132-139. PubMed ID: 26327627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
    Bairwa K; Jachak SM
    J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel surface modified nitrendipine nanocrystals with enhancement of bioavailability and stability.
    Quan P; Shi K; Piao H; Piao H; Liang N; Xia D; Cui F
    Int J Pharm; 2012 Jul; 430(1-2):366-71. PubMed ID: 22531846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
    Jain S; Reddy VA; Arora S; Patel K
    Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced water solubility, antioxidant activity, and oral absorption of hesperetin by D-α-tocopheryl polyethylene glycol 1000 succinate and phosphatidylcholine.
    Gu SF; Wang LY; Tian YJ; Zhou ZX; Tang JB; Liu XR; Jiang HP; Shen YQ
    J Zhejiang Univ Sci B; 2019 Mar.; 20(3):273-281. PubMed ID: 30829014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NanoCrySP technology for generation of drug nanocrystals: translational aspects and business potential.
    Shete G; Bansal AK
    Drug Deliv Transl Res; 2016 Aug; 6(4):392-8. PubMed ID: 26912190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization and in vivo evaluation of amorphous tacrolimus nanosuspensions produced using CO2-assisted in situ nanoamorphization method.
    Wang Y; Han X; Wang J; Wang Y
    Int J Pharm; 2016 May; 505(1-2):35-41. PubMed ID: 27034003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships.
    Swarnakar NK; Thanki K; Jain S
    Mol Pharm; 2014 May; 11(5):1435-49. PubMed ID: 24742138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
    Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
    Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
    Singh H; Jindal S; Singh M; Sharma G; Kaur IP
    Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.